JP2023535366A5 - - Google Patents
Info
- Publication number
- JP2023535366A5 JP2023535366A5 JP2023503124A JP2023503124A JP2023535366A5 JP 2023535366 A5 JP2023535366 A5 JP 2023535366A5 JP 2023503124 A JP2023503124 A JP 2023503124A JP 2023503124 A JP2023503124 A JP 2023503124A JP 2023535366 A5 JP2023535366 A5 JP 2023535366A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- sequence
- acid sequence
- ile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063052502P | 2020-07-16 | 2020-07-16 | |
| US63/052,502 | 2020-07-16 | ||
| PCT/US2021/041737 WO2022015922A1 (en) | 2020-07-16 | 2021-07-15 | Hla class ii-restricted drb t cell receptors against ras with g12v mutation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535366A JP2023535366A (ja) | 2023-08-17 |
| JP2023535366A5 true JP2023535366A5 (enExample) | 2024-07-18 |
Family
ID=77265247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023503124A Pending JP2023535366A (ja) | 2020-07-16 | 2021-07-15 | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｄｒｂ ｔ細胞受容体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230257440A1 (enExample) |
| EP (1) | EP4182029B1 (enExample) |
| JP (1) | JP2023535366A (enExample) |
| KR (1) | KR20230046294A (enExample) |
| CN (1) | CN116348484A (enExample) |
| AU (1) | AU2021309958A1 (enExample) |
| CA (1) | CA3185483A1 (enExample) |
| ES (1) | ES3063075T3 (enExample) |
| WO (1) | WO2022015922A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4297785A4 (en) | 2021-02-26 | 2025-01-22 | New York University | COMPOSITIONS AND METHODS USING ANTIBODIES FOR BINDING TO COVALENT PEPTIDE CONJUGATES |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8034334B2 (en) | 2002-09-06 | 2011-10-11 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| HRP20171164T1 (hr) * | 2010-09-20 | 2017-10-20 | Biontech Cell & Gene Therapies Gmbh | Antigen-specifični t stanični receptori i t stanični epitopi |
| US20120244133A1 (en) | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| CN118994363A (zh) * | 2014-11-26 | 2024-11-22 | 美国卫生和人力服务部 | 抗突变的kras的t细胞受体 |
| ES2879287T3 (es) * | 2015-09-15 | 2021-11-22 | Us Health | Receptores de células T que reconocen KRAS mutado restringido a HLA-cw8 |
| KR20250037592A (ko) * | 2017-09-20 | 2025-03-17 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 돌연변이된 ras에 대한 hla 클래스 ii-제한된 t 세포 수용체 |
| CR20200287A (es) * | 2017-12-04 | 2020-11-11 | Us Health | Receptores de células t restringidos a antígeno leucocitario humano (hla) clase i contra sarcoma de rata (ras) mutado |
| WO2019157279A1 (en) * | 2018-02-10 | 2019-08-15 | Berkeley Lights, Inc. | Mutant idh1 specific t cell receptor |
-
2021
- 2021-07-15 AU AU2021309958A patent/AU2021309958A1/en active Pending
- 2021-07-15 CA CA3185483A patent/CA3185483A1/en active Pending
- 2021-07-15 CN CN202180050745.7A patent/CN116348484A/zh active Pending
- 2021-07-15 US US18/015,781 patent/US20230257440A1/en active Pending
- 2021-07-15 EP EP21752355.4A patent/EP4182029B1/en active Active
- 2021-07-15 WO PCT/US2021/041737 patent/WO2022015922A1/en not_active Ceased
- 2021-07-15 ES ES21752355T patent/ES3063075T3/es active Active
- 2021-07-15 JP JP2023503124A patent/JP2023535366A/ja active Pending
- 2021-07-15 KR KR1020237005176A patent/KR20230046294A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7256794B2 (ja) | 変異型ｒａｓに対するｈｌａクラスｉｉ拘束性ｔ細胞受容体 | |
| Spies et al. | Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer | |
| Orr et al. | Comparison of amino acid sequences of two human histocompatibility antigens, HLA-A2 and HLA-B7: location of putative alloantigenic sites. | |
| RU2752528C2 (ru) | Композиции и библиотеки, содержащие рекомбинантные полинуклеотиды, кодирующие Т-клеточные рецепторы, и способы применения рекомбинантных Т-клеточных рецепторов | |
| JP2021505136A5 (enExample) | ||
| GB2609760A (en) | HLA Class I-restricted T cell receptors against RAS with G12D mutation | |
| EP3615565A1 (en) | Tcr and peptides | |
| JP2020534828A5 (enExample) | ||
| Mesci et al. | NKR-P1 biology: from prototype to missing self | |
| JP2022523024A5 (enExample) | ||
| JP2023534241A5 (enExample) | ||
| JP7742354B2 (ja) | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｔ細胞受容体 | |
| CN120607607A (zh) | 针对含有g12r突变的ras的hla第ii类限制性t细胞受体 | |
| JP2023534241A (ja) | Ｇ１２ｄ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｄｒｂ ｔ細胞受容体 | |
| JP2023535366A5 (enExample) | ||
| Wagner et al. | Structural elements underlying the high binding affinity of human cytomegalovirus UL18 to leukocyte immunoglobulin-like receptor-1 | |
| JP2023540123A5 (enExample) | ||
| TWI900647B (zh) | 識別p53中r273c或y220c突變的t細胞受體 | |
| JP2023535366A (ja) | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｄｒｂ ｔ細胞受容体 | |
| US8658177B2 (en) | Promiscuous HER-2/Neu CD4 T cell epitopes | |
| Hayball et al. | The immune function of MHC class II molecules mutated in the putative superdimer interface | |
| US20230312672A1 (en) | Hla class i-restricted t cell receptors against cd20 | |
| NZ805541A (en) | Hla class i-restricted t cell receptors against mutated ras | |
| EA045621B1 (ru) | T-клеточные рецепторы, рестриктированные по антигену лейкоцитов человека класса ii, против мутантного ras |